ºÐÀÚÇ¥ÀûÄ¡·á(MTT) ½ÃÀåÀ» Á¶»ç ºÐ¼®ÇÑ ÀÚ·á·Î ½ÃÀå±Ô¸ð, »ê¾÷ºÐ¼®, ÇâÈÄ ½ÃÀå¿¹Ãø µîÀÇ ³»¿ëÀ» ´Ù·ç°í ÀÖ½À´Ï´Ù.
![]() |
¼¼°èÀÇ Å°³ª¾ÆÁ¦ ½Å¾à °³¹ß ¼Ö·ç¼Ç ½ÃÀå º¸°í¼ : µ¿Çâ, ¿¹Ãø, °æÀï ºÐ¼®(-2031³â)
Kinase Drug Discovery Solutions Market Report: Trends, Forecast and Competitive Analysis to 2031
¹ßÇà 2025³â 05¿ù
°¡°Ý
US $ 3,850
![]() |
![]() |
Ç¥Àû ´Ü¹éÁú ºÐÇØ ½ÃÀå : ºÐÇØ ÀåÄ¡ À¯Çüº°, ÀûÀÀÁõº°, ÁÖ¿ä Áö¿ªº°
Targeted Protein Degradation Market Distribution by Type of Degrader, Target Indication, Key Geographical Regions (North America, Europe, Asia-Pacific, and Rest of the World )
¹ßÇà 2025³â 05¿ù
°¡°Ý
US $ 4,799
![]() |
![]() |
¼¼°èÀÇ ´ÙÁ߯¯À̼º Ç×ü ½ÃÀå : ¾à¹° ¸ÅÃâ, ¿ë·®, °¡°Ý, ÀÓ»ó½ÃÇè µ¿Çâ(2030³â)
Global Multispecific Antibodies Market, Drug Sales, Dosage, Price & Clinical Trials Insight 2030
¹ßÇà 2025³â 05¿ù
°¡°Ý
US $ 6,000
![]() |
![]() |
Ç×ü °øµ¿ ¿¬±¸ ¹× ¶óÀ̼±½Ì °è¾à(2019-2025³â)
Antibody Collaboration and Licensing Deals 2019-2025
¹ßÇà 2025³â 05¿ù
°¡°Ý
US $ 3,995
![]() |
![]() |
¾Ï ´ÜŬ·ÐÇ×ü °øµ¿ ¿¬±¸ ¹× ¶óÀ̼±½Ì °è¾à(2016-2025³â)
Cancer Monoclonal Antibody Collaboration and Licensing Deals 2016-2025
¹ßÇà 2025³â 05¿ù
°¡°Ý
US $ 3,995
![]() |
![]() |
´ÜŬ·ÐÇ×ü °øµ¿ ¿¬±¸ ¹× ¶óÀ̼±½Ì °è¾à(2019-2025³â)
Monoclonal Antibody Collaboration and Licensing Deals 2019-2025
¹ßÇà 2025³â 05¿ù
°¡°Ý
US $ 3,995
![]() |
![]() |
¼¼°èÀÇ Æ¿µå¶óŰÁÖ¸¿(Tildrakizumab) ½ÃÀå º¸°í¼(2025³â)
Tildrakizumab Global Market Report 2025
¹ßÇà 2025³â 05¿ù
°¡°Ý
US $ 4,490
![]() |
![]() |
¼¼°èÀÇ CD20 Ç×ü ½ÃÀå º¸°í¼(2025³â)
CD20 Antibody Global Market Report 2025
¹ßÇà 2025³â 05¿ù
°¡°Ý
US $ 4,490
![]() |
![]() |
¼¼°èÀÇ CD-19 Ç×ü ½ÃÀå º¸°í¼(2025³â)
CD-19 Antibody Global Market Report 2025
¹ßÇà 2025³â 05¿ù
°¡°Ý
US $ 4,490
![]() |
![]() |
¼¼°èÀÇ ¾ÐŸ¸Ó ½ÃÀå : À¯Çü, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ªº°(2026-2032³â)
Aptamers Market By Type (RNA-Based, DNA-Based), Application (Therapeutics, Diagnostics), End-Users (Academic and Government Research Institutes, Contract Research Organizations), & Region for 2026-2032
¹ßÇà 2025³â 04¿ù
°¡°Ý
US $ 3,950
![]() |
![]() |
ÀϺ»ÀÇ Ç×ü Ä¡·áÁ¦ ½ÃÀå : Á¦Ç° À¯Çüº°, ÀûÀÀ Áúȯº°, Åõ¿© °æ·Îº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°, ±âȸ, ¿¹Ãø(2019-2033³â)
Japan Antibody Therapeutics Market Assessment, By Product Type, By Disease Indication, By Route of Administration, By End-user, By Region, Opportunities and Forecast, FY2019-FY2033F
¹ßÇà 2025³â 04¿ù
°¡°Ý
US $ 3,500
![]() |
![]() |
¼¼°èÀÇ º£¹Ù½ÃÁÖ¸¿(Bevacizumab) - ¹ÙÀÌ¿À½Ã¹Ð·¯ ÀλçÀÌÆ®(2025³â)
Bevacizumab - Biosimilar Insight, 2025
¹ßÇà 2025³â 04¿ù
°¡°Ý
US $ 2,000
![]() |
![]() |
ÀÌÁ߯¯À̼ºÇ×ü ½ÃÀå : ÀÛ¿ë±âÀü, Ä¡·á ºÐ¾ß, ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)
Bispecific Antibodies Market by Mechanism of Action, Therapeutic Area, End-user - Global Forecast 2025-2030
¹ßÇà 2025³â 04¿ù
°¡°Ý
US $ 3,939
![]() |
![]() |
¼¼°èÀÇ Ç×ü Ä¡·áÁ¦ ½ÃÀå : Æ÷¸Ë, Åõ¿© °æ·Î, °ø±Þ¿ø, Áúȯ ¿µ¿ª, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚº° - ¿¹Ãø(2025-2030³â)
Antibody Therapeutics Market by Format, Route of Administration, Source, Disease Areas, Application, End-User - Global Forecast 2025-2030
¹ßÇà 2025³â 04¿ù
°¡°Ý
US $ 3,939
![]() |
![]() |
Ç×ü »ý»ê ½ÃÀå : Á¦Ç° À¯Çü, »ý»ê °øÁ¤, Ŭ·¡½º, Á¤Á¦ ¹æ¹ý, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)
Antibody Production Market by Product, Antibody Type, Production Process, Class, Purification Method, Application, End-User - Global Forecast 2025-2030
¹ßÇà 2025³â 04¿ù
°¡°Ý
US $ 3,939
![]() |
![]() |
¾ÐŸ¸Ó ½ÃÀå : À¯Çü, ±â¼ú, ÇüÅÂ, Ÿ°Ù, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)
Aptamers Market by Type, Technology, Form, Target, Application, End-User - Global Forecast 2025-2030
¹ßÇà 2025³â 04¿ù
°¡°Ý
US $ 3,939
![]() |
![]() |
¼¼°èÀÇ Æ÷À¯·ù ´ÙŬ·Ð ¸é¿ª±Û·ÎºÒ¸° G(IgG) Ç×ü ½ÃÀå º¸°í¼(2025³â)
Mammalian Polyclonal Immunoglobulin G (IgG) Antibody Global Market Report 2025
¹ßÇà 2025³â 04¿ù
°¡°Ý
US $ 4,490
![]() |
![]() |
´ÜÀÏŬ·ÐÇ×ü(mAbs) ½ÃÀå : »ý»ê ¹æ¹ýº°, À¯·¡º°, ÀûÀÀÁõº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°(2025-2033³â)
Monoclonal Antibodies Market Report by Production Method, Source, Indication, End Use, and Region 2025-2033
¹ßÇà 2025³â 04¿ù
°¡°Ý
US $ 2,999
![]() |
![]() |
PTPN2 ¾ïÁ¦Á¦ : Àü·«Àû ½ÃÀå ÀλçÀÌÆ®¿Í ÆÄÀÌÇÁ¶óÀÎ Àü¸Á(2025³â)
PTPN2 Inhibitors: Strategic Market Insights & Pipeline Outlook - 2025
¹ßÇà 2025³â 04¿ù
°¡°Ý
US $ 2,800
![]() |
![]() |
µ¿¹° ÀÇ·á¿ë ¸ð³ëŬ·Î³Î Ç×ü ½ÃÀå : ¼¼°è »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø - µ¿¹° À¯Çüº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°, °æÀﺰ(2020-2030³â)
Monoclonal Antibodies In Veterinary Health Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Animal Type, By Application, End-User, By Region, & Competition, 2020-2030F
¹ßÇà 2025³â 03¿ù
°¡°Ý
US $ 4,500
![]() |
![]() |
Ç×ü¾à¹°Á¢ÇÕü ½ÃÀå : ¼¼°è »ê¾÷ ±Ô¸ð, µ¿Çâ, ±âȸ, ¿¹Ãø - À¯Çüº°, ¿ëµµº°, Áö¿ªº°, °æÀﺰ(2020-2030³â)
Antibody Drug Conjugates Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Types, By Application, By Region & Competition, 2020-2030F
¹ßÇà 2025³â 03¿ù
°¡°Ý
US $ 4,500
![]() |
![]() |
¼¼°èÀÇ Ç×CD20 ¸ð³ëŬ·Î³Î Ç×ü(mAB) ½ÃÀå(2025-2029³â)
Global Anti-cd20 Monoclonal Antibodies (mabs) Market 2025-2029
¹ßÇà 2025³â 03¿ù
°¡°Ý
US $ 2,500
![]() |
![]() |
ŰƮ·ç´Ù(Keytruda) ½ÃÀå : ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼ - ¿ëµµº°, ÁöºÒÀÚº°, À¯Åë ä³Îº°, Áö¿ªº°, ºÎ¹® ¿¹Ãø(2025-2030³â)
Keytruda Market Size, Share & Trends Analysis Report By Application (Lung Cancer, Breast Cancer, Melanoma, Hodgkin Lymphoma), By Payer (Commercial/Private, Public), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
¹ßÇà 2025³â 03¿ù
°¡°Ý
US $ 5,950
![]() |
![]() |
ÀÌÁß Æ¯À̼º Ç×ü ½ÃÀå : Ä¡·á ¿µ¿ªº°, ÀÛ¿ë±âÀüº°, Ç¥Àû Ç׿øº°, Ç×ü Æ÷¸Ëº°, ÁÖ¿ä Áö¿ªº°, ÁÖ¿ä ±â¾÷º° - ¾÷°è µ¿Çâ°ú ¼¼°è ¿¹Ãø(- 2035³â)
Bispecific Antibodies Market by Therapeutic Area, Mechanism of Action Target Antigen, Antibody Format, Key Geographical Regions and Key Players: Industry Trends and Global Forecasts, Till 2035
¹ßÇà 2025³â 03¿ù
°¡°Ý
US $ 4,799
![]() |
![]() |
ºÐÀÚ¼¼Æ÷À¯ÀüÇÐ ½ÃÀå : ½ÃÀå Á¡À¯À² ºÐ¼®, »ê¾÷ µ¿Çâ ¹× Åë°è, ¼ºÀå ¿¹Ãø(2025-2030³â)
Molecular Cytogenetics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
¹ßÇà 2025³â 03¿ù
°¡°Ý
US $ 4,750
![]() |